Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtrer
Plus de filtres











Gamme d'année
1.
Int Braz J Urol ; 42(4): 825-37, 2016.
Article de Anglais | MEDLINE | ID: mdl-27564297

RÉSUMÉ

INTRODUCTION: We investigate the effect of active peptide from Urechis unicinctus (UU) by high temperature/pressure and ultra-wave assisted lysis on erectile dysfunction in streptozotocin-induced diabetic rats. MATERIALS AND METHODS: Forty 12-week-old Sprague-Dawley rats were used in this study. Diabetes was induced by a one-time intraperitoneal injection of streptozotocin (50mg/kg). One week later, the diabetic rats were randomly divided into four groups: normal control, untreated diabetes control, and groups treated with 100 or 500mg/kg/d UU peptide. Rats were fed with UU peptide by intragastric administration for 8 weeks. After 8 weeks, penile hemodynamic function was evaluated in all groups by measuring the intracavernosal pressure after electrostimulating the cavernous nerve. Nitric oxide (NO) and cyclic guanosine monophosphate (cGMP) activities were measured and endothelial nitric oxide synthase (eNOS) and neuronal NOS (nNOS) protein expression. was determined by Western blot. RESULTS: Maximum intracavernosal pressure in diabetic control rats decreased significantly compared to normal control rats, and was increased significantly compared to untreated diabetic rats after UU peptide supplementation. Treatment with the higher dose of UU peptide significantly increased the NO and cGMP levels compared with the diabetic control group. Decreased activity and expression eNOS and nNOS were found in the diabetic rats compared with the normal control group. Decreased eNOS and nNOS in diabetic rats were improved by UU peptide administration. CONCLUSIONS: Active peptide from UU ameliorates erectile function in a streptozotocin induced diabetic rat model of erectile dysfunction.


Sujet(s)
Annelida/composition chimique , Diabète expérimental/complications , Dysfonctionnement érectile/traitement médicamenteux , Peptides/pharmacologie , Animaux , Cellules cultivées , Diabète expérimental/induit chimiquement , Dysfonctionnement érectile/étiologie , Dysfonctionnement érectile/physiopathologie , Mâle , Pénis/effets des médicaments et des substances chimiques , Peptides/analyse , Peptides/usage thérapeutique , Répartition aléatoire , Rats , Rat Sprague-Dawley , Streptozocine , Température
2.
Int. braz. j. urol ; 42(4): 825-837, July-Aug. 2016. tab, graf
Article de Anglais | LILACS | ID: lil-794686

RÉSUMÉ

ABSTRACT Introduction: We investigate the effect of active peptide from Urechis unicinctus (UU) by high temperature/pressure and ultra-wave assisted lysis on erectile dysfunction in streptozotocin-induced diabetic rats. Materials and Methods: Forty 12-week-old Sprague-Dawley rats were used in this study. Diabetes was induced by a one-time intraperitoneal injection of streptozotocin (50mg/kg). One week later, the diabetic rats were randomly divided into four groups: normal control, untreated diabetes control, and groups treated with 100 or 500mg/kg/d UU peptide. Rats were fed with UU peptide by intragastric administration for 8 weeks. After 8 weeks, penile hemodynamic function was evaluated in all groups by measuring the intracavernosal pressure after electrostimulating the cavernous nerve. Nitric oxide (NO) and cyclic guanosine monophosphate (cGMP) activities were measured and endothelial nitric oxide synthase (eNOS) and neuronal NOS (nNOS) protein expression was determined by Western blot. Results: Maximum intracavernosal pressure in diabetic control rats decreased significantly compared to normal control rats, and was increased significantly compared to untreated diabetic rats after UU peptide supplementation. Treatment with the higher dose of UU peptide significantly increased the NO and cGMP levels compared with the diabetic control group. Decreased activity and expression eNOS and nNOS were found in the diabetic rats compared with the normal control group. Decreased eNOS and nNOS in diabetic rats were improved by UU peptide administration. Conclusions: Active peptide from UU ameliorates erectile function in a streptozotocin induced diabetic rat model of erectile dysfunction.


Sujet(s)
Animaux , Mâle , Rats , Peptides/pharmacologie , Diabète expérimental/complications , Dysfonctionnement érectile/traitement médicamenteux , Annelida/composition chimique , Pénis/effets des médicaments et des substances chimiques , Peptides/analyse , Peptides/usage thérapeutique , Température , Répartition aléatoire , Cellules cultivées , Rat Sprague-Dawley , Streptozocine , Diabète expérimental/induit chimiquement , Dysfonctionnement érectile/étiologie , Dysfonctionnement érectile/physiopathologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE